01099 國藥控股
按盤價 
19.940 +0.240 (+1.218%) | 2023/12 - 末期 人民幣(千¥) | 2022/12 人民幣(千¥) | 2021/12 人民幣(千¥) | 2020/12 人民幣(千¥) | 2019/12 人民幣(千¥) | |
| 經營活動之現金流量 | 17,173,030 | 20,963,787 | 9,308,085 | 11,154,609 | 18,777,096 |
| 投資活動之現金流量 | (944,535) | (3,589,622) | (1,266,962) | (2,202,758) | (6,795,967) |
| 融資活動之現金流量 | (7,643,970) | (5,693,481) | (14,693,007) | 2,025,854 | (13,084,565) |
| 現金及等同現金之增加/(減少) | 8,584,525 | 11,680,684 | (6,651,884) | 10,977,705 | (1,103,436) |
| 期初之現金及現金等價物 | 55,221,624 | 43,529,428 | 50,178,265 | 39,191,967 | 40,298,985 |
| 匯率變動之影響 | 2,389 | 11,512 | 3,047 | 8,593 | (3,582) |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之現金及現金等價物 | 63,808,538 | 55,221,624 | 43,529,428 | 50,178,265 | 39,191,967 |
| 股東應佔溢利/(虧損) (千) | RMB 9,053,760 |
| 增長率 | 6.194% |
| 每股盈利/(虧損) | RMB 2.900 |
| 每股帳面資產淨值 (¥) | RMB 23.900 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
